Consumer advocates and the media have commented in recent years on the need for transparency and disclosure of financial interests related to payments made to physicians by pharmaceutical and medical device manufacturers. In 2009, the US Senate reintroduced the Physician Payments Sunshine Act; and on March 23, 2010, the Patient Protection and Affordable Health Care Act of 2009 (the “Act”) was signed into law. These manufacturers must capture payment information beginning in January 2012 to determine their ability to comply with the first reporting requirement in March 2013.